Hanna Lesch
Chief Technology Officer • Exothera
Hanna has dedicated her career to gene therapy and has held several director positions including leading research and development at FKD Therapies, Kuopio Center for Cell & Gene Therapy and Finvector. Hanna holds several member and executive board positions in industry associations, is an adjunct professor at the University of Eastern Finland and is a frequent speaker at cell and gene therapy industry events.
Also Speaking
Mark Roache
Vice President, Cell and Gene Therapies • Quality Executive Partners / Virtuosi
12 December 2022
Lili Belcastro
Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb
24 November 2022
Andreas Kouri
Senior Vice President, Supply Chain Strategic Operations • ElevateBio
17 November 2022
Event Info
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
